Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,069 public trials 1,836 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Active, Not Recruiting

Study Evaluating Safety, Tolerability and Pharmacokinetics (PK) of Tarlatamab in Adults With Small Cell Lung Cancer (SCLC)

NCT03319940

Conditions
Bites and Stings, Bronchial Neoplasms, Carcinoma, Bronchogenic, +11 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Yale New Haven Hospital New Haven, Connecticut, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Winship Cancer Institute Atlanta, Georgia, United States
View all 39 locations
View Trial Details
Active, Not Recruiting

Study of ctDNA as Prognostic Factor on Resectable Stage IIIA NSCLC Patients Treated With Neoadjuvant Treatment

NCT05382052

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Hospital Universitario De A Coruna A Coruña, Spain
  • Hospital General Universitario de Alicante Alicante, Spain
  • Hospital Germans Trias I Pujol Badalona, Barcelona, Spain
  • Hospital Universitari Quiron Dexeus Barcelona, Spain
View all 20 locations
View Trial Details
Active, Not Recruiting

Combination of Paclitaxel-bevacizumab ± Atezolizumab in Patients With Advanced NSCLC Progressing After Immunotherapy & Chemotherapy

NCT05781308

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • CHU Amiens Amiens, France
  • CHU d'Angers Angers, France
  • CH Avignon Avignon, France
  • CH Côte Basque Bayonne, France
View all 44 locations
View Trial Details
Active, Not Recruiting

DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer

NCT04042701

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
Locations
  • Univ. of Cali. San Francisco Medical Center San Francisco, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Cancer Specialists of North Florida (Cbo) Jacksonville, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 30 locations
View Trial Details
Active, Not Recruiting

ENCOrafenib With Binimetinib in bRAF NSCLC

NCT04526782

Conditions
BRAF V600E, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Annemasse - CH Ambilly, France
  • Angers - CHU Angers, France
  • Avignon - Institut Sainte-Catherine Avignon, France
  • Bordeaux - Institut Bergonié Bordeaux, France
View all 36 locations
View Trial Details
Active, Not Recruiting

A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors

NCT05812027

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +43 more
Locations
  • HonorHealth Research and Innovation Institute Scottsdale, Arizona, United States
  • University of California San Diego San Diego, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Memorial Healthcare System Hollywood, Florida, United States
View all 21 locations
View Trial Details
Active, Not Recruiting

Study of Safety and Efficacy of Brigatinib Plus Chemotherapy or Brigatinib Only in Advanced ALK-Positive Lung Cancer (MASTERPROTOCOL ALK)

NCT05200481

Conditions
ALK Gene Mutation, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • CHU d'Angers Angers, France
  • CHU Besançon - Hôpital J. MINJOZ Besançon, France
  • Hôpital APHP Ambroise Paré Boulogne, France
  • Hospices Civils de Lyon - Hôpital Louis Pradel Bron, France
View all 29 locations
View Trial Details

Related conditions